intern
outbreak
sever
acut
respiratori
syndrom
sar
strong
infect
pathogen
spread
countri
infect
peopl
kill
emerg
midnovemb
august
fouchier
et
al
caus
agent
sar
subsequ
identifi
novel
coronaviru
name
sarscoronaviru
sarscov
drosten
et
al
peiri
et
al
sarscov
phylogenet
differ
member
coronavirida
famili
coronaviru
current
known
caus
sever
morbid
mortal
human
lee
et
al
sarscov
encod
four
main
structur
protein
spike
glycoprotein
membran
protein
envelop
e
protein
nucleocapsid
n
protein
rota
et
al
stadler
et
al
n
protein
mani
coronavirus
highli
immunogen
abundantli
express
infect
liu
et
al
narayanan
et
al
n
protein
felin
infecti
periton
viru
fipv
use
subunit
vaccin
induc
protect
immun
prevent
progress
diseas
cat
model
hohdatsu
et
al
porcin
coronaviru
transmiss
gastroenter
viru
tgev
n
protein
repres
antigen
tcell
respons
may
induc
cellular
humor
immun
respons
anton
et
al
result
indic
good
n
protein
vaccin
candid
elicit
strong
immun
respons
moreov
sarscov
n
protein
highli
conserv
within
differ
isol
share
amino
acid
homolog
n
protein
coronavirus
rota
et
al
thu
n
protein
import
target
sarscov
vaccin
develop
immunogen
sarscov
n
protein
investig
long
time
antibodi
n
protein
last
longer
occur
greater
abund
sar
patient
antibodi
viral
compon
e
protein
chen
et
al
kim
et
al
tan
et
al
timani
et
al
zhu
et
al
phenomenon
might
due
higher
express
n
protein
compar
viral
protein
sarscov
infect
rota
et
al
n
protein
may
therefor
play
crucial
role
antibodi
respons
sarscov
infect
might
use
earli
diagnosi
infect
vaccin
develop
moreov
vaccin
plasmid
express
nucleocapsid
protein
capabl
gener
strong
nspecif
humor
cellular
immun
respons
vaccin
mice
kim
et
al
zhao
et
al
zhu
et
al
therefor
base
observ
initi
focus
sarscov
n
protein
target
antigen
dna
vaccin
develop
dna
vaccin
induc
cellular
humor
immun
respons
produc
longlast
immun
infecti
diseas
howev
low
immunogen
dnabas
vaccin
could
compromis
applic
recent
year
mani
effort
direct
toward
enhanc
immun
respons
elicit
dna
vaccin
includ
coexpress
cytokin
use
heterolog
primeboost
regim
convent
rout
deliveri
dna
vaccin
sever
cytokin
act
immunolog
adjuv
inactiv
subunit
vaccin
well
dna
vaccin
barouch
et
al
chow
et
al
kim
et
al
nobiron
et
al
immun
respons
dna
vaccin
enhanc
dramat
coadministr
plasmid
encod
gene
exampl
dna
vaccin
bovin
herpesviru
viru
kuhnl
et
al
hepat
c
viru
geissler
et
al
hepat
b
viru
chow
et
al
bovin
viral
diarrhea
viru
nobiron
et
al
hiv
moor
et
al
footandmouth
diseas
wong
et
al
measl
viru
premenkolani
et
al
current
studi
demonstr
gene
cytokin
adjuv
could
increas
immun
respons
sarscov
nucleocapsid
dna
vaccin
pcdnan
plasmid
use
studi
dna
fragment
encod
fulllength
n
gene
amplifi
cdna
sarscov
strain
genbank
access
dna
fragment
subclon
mammalian
express
vector
invitrogen
carlsbad
ca
construct
recombin
plasmid
pcdnan
gene
kindli
provid
prof
cui
boan
henan
agricultur
univers
zhengzhou
peopl
republ
china
subclon
construct
recombin
plasmid
accuraci
construct
confirm
restrict
digest
sequenc
largescal
plasmid
prepar
purif
conduct
use
endofre
plasmid
maxi
kit
qiagen
inc
chatsworth
ca
accord
manufactur
protocol
dna
dissolv
endotoxinfre
phosphatebuff
salin
pb
sigma
final
concentr
store
pcdnan
construct
transient
transfect
cell
protein
express
effici
detect
anim
immun
conduct
anim
experi
employ
laboratori
anim
approv
hubei
provinc
laboratori
anim
manag
committe
scxk
ea
china
briefli
eightweekold
balbc
mice
purchas
experiment
anim
center
hubei
medic
colleg
randomli
divid
five
group
mice
anim
receiv
pathogenfre
water
food
mainten
mice
immun
three
time
pcdnan
alon
pcdnan
plu
day
immun
deliv
quadricep
muscl
total
volum
pb
dna
dosag
use
mice
immun
scheme
optim
seri
preliminari
experi
antibodi
sarscov
serum
test
enzymelink
immunosorb
assay
elisa
describ
previous
hu
et
al
chemic
kill
sarscov
kindli
provid
prof
chen
z
wuhan
institut
virolog
chines
academi
scienc
peopl
republ
china
use
detect
antigen
optim
concentr
antigen
coat
onto
plate
costar
overnight
plate
wash
block
bovin
serum
albumin
bsa
buffer
solut
h
prior
h
incub
dilut
mous
sera
bound
antibodi
detect
alkalin
phosphataseconjug
goatantimous
igg
sigma
color
develop
ad
pnitrophenyl
phosphat
pnpp
substrat
read
nm
plate
reader
valu
mous
serum
experiment
group
consid
posit
equal
obtain
control
group
valu
lower
includ
similar
elisa
protocol
follow
assess
nspecif
immunoglobulin
igg
subclass
case
recombin
n
protein
express
e
coli
purifi
use
detect
antigen
horseradish
peroxidas
hrp
conjug
goatantimous
igg
sigma
use
secondari
antibodi
determin
antigenspecif
tcell
prolifer
lpa
perform
describ
previous
froebel
et
al
brief
week
follow
final
inject
mice
sacrif
singlecel
suspens
prepar
spleen
group
splenocyt
per
well
medium
sigma
supplement
fb
seed
plate
triplic
cultur
stimul
variou
condit
h
concanavalin
posit
control
purifi
n
antigen
specif
antigen
bsa
irrelev
antigen
medium
alon
neg
control
celltit
aqueou
one
solut
reagent
promega
usa
ad
well
accord
manufactur
protocol
follow
h
incub
absorb
read
nm
prolif
activ
estim
use
stimul
index
si
defin
mean
od
antigencontain
well
divid
mean
od
well
without
antigen
cellular
immun
respons
sarscov
assess
enzymelink
immunospot
elispot
assay
use
mous
splenocyt
assay
perform
accord
instruct
manual
ucytech
netherland
ninetysixwel
plate
coat
rat
antimous
pb
overnight
plate
wash
three
time
pb
contain
block
pb
contain
fb
h
three
wash
pb
contain
splenocyt
reaction
buffer
contain
purifi
n
proteinml
ad
well
plate
incub
h
wash
time
pb
biotinyl
antimous
mab
dilut
subsequ
ad
plate
incub
h
room
temperatur
wash
avidinhorseradish
peroxidas
ad
anoth
h
incub
room
temperatur
follow
five
wash
pb
individu
plate
develop
dark
spot
min
reaction
peroxidas
substrateaec
reaction
stop
rins
plate
demineralis
water
plate
airdri
room
temperatur
read
use
elispot
reader
hitech
instrument
spot
form
cell
sfc
per
splenocyt
calcul
medium
background
consist
sfc
per
splenocyt
flow
cytometri
use
monitor
express
cell
surfac
marker
direct
immunofluoresc
perform
accord
standard
techniqu
describ
elsewher
caruso
et
al
two
week
follow
final
inject
blood
collect
mous
eye
pit
vaccin
group
peripher
blood
mononuclear
cell
pbmc
isol
isopaqueficol
lymphoprep
nycom
oslo
norway
follow
manufactur
instruct
lymphocyt
isol
pbmc
stain
follow
mab
fitclabel
antimous
antibodi
antimous
antibodi
pelabel
antimous
antibodi
bd
pharmingen
correspond
isotyp
control
stain
lymphocyt
wash
three
time
pb
contain
fetal
bovin
serum
cell
acquir
facscalibur
flow
cytomet
beckton
dickinson
lincoln
park
nj
data
analyz
use
winmdi
softwar
data
present
mean
sd
immun
mice
per
group
differ
humor
cellular
immun
respons
group
assay
use
singl
factor
analysi
varianc
lsd
ttest
use
betweengroup
comparison
valu
p
consid
statist
signific
express
dna
construct
analyz
vitro
data
shown
balbc
mice
inocul
intramuscularli
im
three
time
quadricep
muscl
separ
recombin
dna
plasmid
interv
antibodi
sarscov
analyz
indirect
elisa
sera
sampl
collect
day
first
immun
blood
sera
mice
immun
either
pcdnan
pcdnan
plu
could
strongli
detect
sarscov
fig
blood
sera
collect
control
group
inject
pcdna
pb
respect
show
signific
level
immun
respons
day
pcdnan
plu
immun
group
show
detect
level
immun
respons
wherea
pcdnan
group
show
limit
immun
respons
immun
process
antibodi
level
coadminist
group
significantli
higher
pcdnan
alon
group
second
immun
boost
p
two
week
final
immun
nspecif
antibodi
measur
elisa
fig
vaccin
mice
develop
substanti
nspecif
antibodi
respons
wherea
anim
control
group
show
detect
nspecif
antibodi
respons
express
nspecif
igg
antibodi
consist
express
pattern
antibodi
sarscov
immun
group
fig
measur
order
detect
humor
cytotox
immun
respons
respect
shown
fig
antinspecif
igg
subtyp
profil
reveal
induc
pcdnan
pcdnan
plu
immun
regimen
antibodi
level
combin
group
show
higher
degre
increas
compar
pcdnan
vaccin
group
although
antibodi
subclass
profil
similar
group
coadministr
pcdnan
mainli
enhanc
antibodi
respons
chang
antibodi
subclass
determin
whether
tcell
prolifer
respons
dna
vaccin
encod
n
gene
may
boost
express
vector
splenocyt
vaccin
mice
examin
antigenspecif
tcell
prolifer
shown
fig
dna
vaccin
plu
group
well
dna
vaccin
group
exhibit
higher
level
cell
prolif
respons
restimul
purifi
sarscov
n
protein
mice
vaccin
pb
respond
n
protein
p
coimmun
induc
substanti
increas
tcell
prolifer
respons
compar
pcdnan
vaccin
group
alon
p
effect
magnitud
tcell
induc
pcdnan
pcdnan
plu
plasmid
investig
use
elispot
assay
protein
dosag
use
stimul
number
splenocyt
optim
induc
tcell
respons
data
shown
splenocyt
vaccin
mice
harvest
week
final
vaccin
nspecif
elispot
enumer
shown
fig
b
low
number
nonspecif
elispot
detect
control
group
pb
spot
cell
wherea
control
group
number
cell
higher
neg
control
group
pb
p
much
lower
pcdnan
pcdnan
plu
group
fig
compar
neg
control
group
signific
number
nspecif
elispot
detect
pcdnan
pcdnan
plu
immun
group
p
immun
pcdnan
induc
nspecif
cell
comparison
adjuv
nspecif
tcell
frequenc
increas
cell
increas
number
tcell
prime
immun
pcdnan
p
howev
cell
number
vaccin
group
high
cell
number
coadministr
also
appreci
enhanc
cell
number
increas
compar
pcdnan
immun
alon
activ
lymphocyt
among
crucial
compon
antivir
effector
cell
subset
pbmc
vaccin
mice
assess
fig
flow
cytometri
analysi
unstimul
cell
use
standard
background
respons
littl
variat
nonimmun
mice
pcdnan
pcdnan
plu
vaccin
significantli
increas
percentag
activ
cell
compar
control
group
p
number
activ
cell
increas
immun
group
ratio
pcdnan
plu
group
higher
pcdnan
group
sarscov
n
protein
import
target
cellular
humor
immun
respons
sarscov
previou
studi
shown
n
protein
dna
encod
n
gene
elicit
antibodi
cytotox
tcell
respons
mice
barouch
et
al
liu
et
al
zhu
et
al
kim
et
al
also
demonstr
vaccin
n
dna
vaccin
could
success
induc
sarscov
antigenspecif
tcell
respons
distinctli
reduc
titer
recombin
vaccinia
viru
express
sarscov
n
protein
challeng
coexpress
calreticulin
crt
n
gene
could
enhanc
abil
protect
viral
challeng
kim
et
al
result
support
basic
role
n
protein
import
compon
sarscov
vaccin
therefor
present
experi
focus
sarscov
n
protein
target
antigen
dna
vaccin
develop
previou
studi
sarscov
n
dna
vaccin
approach
investig
use
differ
immun
rout
mous
model
clearli
show
administr
n
dna
vaccin
candid
via
differ
immun
rout
could
induc
qualit
differ
immun
respons
profil
hu
et
al
shown
intramuscularli
vaccin
sarscov
n
dna
elicit
sarscov
nspecif
humor
cellular
immun
respons
respons
could
significantli
enhanc
coadministr
vector
thu
abil
dna
immun
strategi
enhanc
cellular
humor
immun
respons
confirm
two
distinct
system
result
humor
cellularmedi
nspecif
respons
induc
mice
n
dna
plasmid
nspecif
igg
antibodi
elicit
immun
anim
compar
level
antibodi
higher
level
antibodi
induc
addit
cell
prolifer
ratio
activ
cell
also
success
evok
n
dna
vaccin
also
found
antigenspecif
cell
capabl
secret
high
level
cytokin
moder
level
cytokin
upon
vitro
stimul
sarscov
n
protein
find
suggest
n
dna
vaccin
effect
activ
b
tcell
gener
antin
antibodi
cellular
immun
mainli
respons
mous
model
result
consist
former
studi
n
protein
dna
vaccin
liu
et
al
zhao
et
al
critic
prolifer
clonal
expans
antigenspecif
cell
sever
line
evid
suggest
coadministr
plasmid
encod
gene
given
antigen
result
enhanc
humor
cellmedi
immun
respons
antigen
mostli
favor
cell
differenti
geissler
et
al
kuhnl
et
al
moor
et
al
nobiron
et
al
sin
et
al
wong
et
al
current
studi
basi
examin
immun
respons
induc
n
dna
vaccin
test
abil
improv
immunogen
sarscov
n
dna
vaccin
result
clearli
demonstr
immunogen
n
dna
vaccin
significantli
enhanc
coadministr
express
plasmid
studi
antigenspecif
humor
immun
respons
coimmun
group
antibodi
respons
induc
coadministr
pcdnan
plu
significantli
higher
induc
vaccin
pcdnan
alon
p
product
antibodi
induc
coadministr
plasmid
began
week
earlier
induc
pcdnan
administr
alon
fig
observ
suggest
antibodi
silent
period
becom
shorter
use
adjuv
could
help
control
infect
soon
sarscov
infect
moreov
known
promot
respons
may
use
vaccin
adjuv
diseas
cellmedi
immun
play
import
role
protect
pathogen
chow
et
al
publish
data
show
n
gene
play
import
role
cellular
immun
respons
sarscov
infect
kim
et
al
zhao
et
al
zhu
et
al
studi
antigenspecif
cellular
immun
respons
lymphocyt
elispot
assay
employ
assess
frequenc
cytokin
produc
cell
kind
cell
produc
cultur
lymphocyt
isol
coimmun
mice
result
show
immun
pcdnan
plu
elicit
signific
level
tcell
respons
respons
higher
pcdnan
alon
group
elispot
fac
data
confirm
result
use
elispot
assay
measur
number
antigenspecif
tcell
per
million
splenocyt
found
significantli
increas
stimul
function
reflect
increas
releas
cell
reflect
increas
releas
higher
level
product
compar
fig
suggest
vaccin
combin
induc
immun
respons
find
consist
abil
combin
vaccin
activ
cd
cell
strong
mild
cell
increas
thu
present
result
indic
synergist
action
result
strong
activ
sarscov
nspecif
lymphocyt
wit
high
product
might
suffici
viral
clearanc
anim
human
sarscov
infect
observ
strongli
suggest
enhanc
humor
immun
respons
also
cellmedi
respons
trigger
dna
vaccin
coinject
gene
dna
immun
enhanc
develop
cell
predomin
cell
result
consist
previou
report
show
coexpress
immunestimulatori
could
increas
immun
respons
coxsackieviru
princip
toward
henk
et
al
convers
chow
report
coinject
gene
dna
immun
studi
enhanc
develop
cell
activ
affect
chow
et
al
agreement
result
howev
differ
result
could
due
differ
natur
antigen
use
respect
studi
find
suggest
report
strategi
use
vaccin
sarscov
well
promis
cytokin
adjuv
sarscov
dna
vaccin
perhap
coronaviru
dna
vaccin
futur
howev
effect
mice
may
dramat
human
signific
limit
current
technolog
prevent
full
effect
dna
vaccin
larger
anim
whether
approach
could
appli
anim
model
still
unknown
immunogen
human
remain
establish
therefor
import
evalu
efficaci
sar
dna
vaccin
strategi
highli
relev
translat
model
demonstr
human
immun
respons
